NCT05735652Completed
An Observational Study of Radiotherapy After Injection of SpaceOAR Hydrogel
An Observational Study to Evaluate the Safety and Effectiveness of Radiotherapy for Localized T1-T2 Prostate Cancer in China After Injection of SpaceOAR Hydrogel
Source: ClinicalTrials.gov · Last updated 30 May 2025
Brief summary (registry, in English)
This observational study aims to evaluate the safety and effectiveness of radiotherapy for subjects with localized T1-T2 prostate cancer in China who were injected with SpaceOAR Hydrogel, via collecting clinical data related to radiotherapy.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 14 (actual)
- First submitted
- 22 Aug 2022
- Start date
- 3 Nov 2022
- Primary completion date
- 30 Apr 2024
- Lead sponsor
- Boston Scientific Corporation
- Diseases
- Prostate cancer, Childhood cancers
- NCT number
- NCT05735652
What you commit to
- Study type: Observational
- Participants enrolled: 14
- From 3 Nov 2022 to the primary completion date, 30 Apr 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- All subjects have received radiotherapy or will receive radiotherapy, who have injected with SpaceOAR hydrogel in Boao Medical Pilot Zone.
Other
- There is no specific exclusion criteria unless the patients refuse to sign the informed consent.
Who the study is looking for
- Subjects have provided the written informed consent, are willing to participate in clinical data collection and willing to comply with study procedure. (for subjects enrolled prospectively)
- Subjects must have been pathologically confirmed prostate cancer with clinical stage T1-T2, and have been treated with Space OAR Hydrogel, and have received or will receive radiotherapy.
Sex: Male · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Shanxi Cancer hospital Coordinator of this site? Confirm its status | Taiyuan | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.